drugset / Trial / NCT00557505
A Study Of PF-03732010 In Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
P-cadherin may play a part in tumor growth; PF-03732010 is a new drug that inhibits P-cadherin. This study will test how well the drug is tolerated, and what effects there might be. Blood will also be taken to measure the amount of drug in blood.
Timeline
- Start
- 2007-12
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03732010 | Unknown | 0.5 mg/kg | Intravenous |